<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10910000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P41597</UniProt_ID>
  <Seq_Length>374</Seq_Length>
  <Molecule_Weight>41915</Molecule_Weight>
  <KEGG_ID>hsa:729230</KEGG_ID>
  <Orthology_ID>K04177</Orthology_ID>
  <Function_Summary>Receptor for the MCP-1, MCP-3 and MCP-4 chemokines. Transduces a signal by increasing the intracellular calcium ions level. Alternative coreceptor with CD4 for HIV-1 infection.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Monocyte chemoattractant protein 1 receptor</Alias>
      <Alias>C-C CKR-2</Alias>
      <Alias>MCP-1-R</Alias>
      <Alias>CCR-2</Alias>
      <Alias>CC-CKR-2</Alias>
      <Alias>CCR2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with chemokines, small chemoattractant molecules normally used to stimulate leukocytes, to initiate a change in cell activity.</Detail>
      <Keyword>Chemokine receptor activity</Keyword>
      <Ontology_ID>GO:0004950</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with a C-C chemokine to initiate a change in cell activity. C-C chemokines do not have an amino acid between the first two cysteines of the characteristic four-cysteine motif.</Detail>
      <Keyword>C-C chemokine receptor activity</Keyword>
      <Ontology_ID>GO:0016493</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a CCR2 chemokine receptor.</Detail>
      <Keyword>CCR2 chemokine receptor binding</Keyword>
      <Ontology_ID>GO:0031727</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>64</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>355</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The reorganization or renovation of existing blood vessels.</Detail>
      <Keyword>Blood vessel remodeling</Keyword>
      <Ontology_ID>GO:0001974</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.</Detail>
      <Keyword>Positive regulation of interleukin-2 production</Keyword>
      <Ontology_ID>GO:0032743</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A defense response that is mediated by cells.</Detail>
      <Keyword>Cellular defense response</Keyword>
      <Ontology_ID>GO:0006968</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the concentration of calcium ions in the cytosol.</Detail>
      <Keyword>Elevation of cytosolic calcium ion concentration</Keyword>
      <Ontology_ID>GO:0007204</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate, or extent of production of vascular endothelial growth factor.</Detail>
      <Keyword>Regulation of vascular endothelial growth factor production</Keyword>
      <Ontology_ID>GO:0010574</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate, or extent of monocyte chemotaxis.</Detail>
      <Keyword>Positive regulation of monocyte chemotaxis</Keyword>
      <Ontology_ID>GO:0090026</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of a T-helper 1 type immune response.</Detail>
      <Keyword>Positive regulation of T-helper 1 type immune response</Keyword>
      <Ontology_ID>GO:0002827</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.</Detail>
      <Keyword>Positive regulation of interferon-gamma production</Keyword>
      <Ontology_ID>GO:0032729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The movement of a dendritic cell in response to an external stimulus.</Detail>
      <Keyword>Dendritic cell chemotaxis</Keyword>
      <Ontology_ID>GO:0002407</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell extravasation.</Detail>
      <Keyword>Positive regulation of CD8-positive, alpha-beta T cell extravasation</Keyword>
      <Ontology_ID>GO:2000451</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus.</Detail>
      <Keyword>Positive regulation of T cell chemotaxis</Keyword>
      <Ontology_ID>GO:0010820</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which STAT proteins (Signal Transducers and Activators of Transcription) are activated by members of the JAK (janus activated kinase) family of tyrosine kinases, following the binding of cytokines to their cognate receptor. Once activated, STATs dimerize and translocate to the nucleus and modulate the expression of target genes.</Detail>
      <Keyword>JAK-STAT cascade</Keyword>
      <Ontology_ID>GO:0007259</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Interactions, directly with the host cell macromolecular machinery, to allow virus replication.</Detail>
      <Keyword>Virus-host interaction</Keyword>
      <Ontology_ID>GO:0019048</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the rate of eosinophil degranulation.</Detail>
      <Keyword>Negative regulation of eosinophil degranulation</Keyword>
      <Ontology_ID>GO:0043310</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of adenylate cyclase activity.</Detail>
      <Keyword>Negative regulation of adenylate cyclase activity</Keyword>
      <Ontology_ID>GO:0007194</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.</Detail>
      <Keyword>Positive regulation of tumor necrosis factor biosynthetic process</Keyword>
      <Ontology_ID>GO:0042535</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of a type 2 immune response.</Detail>
      <Keyword>Negative regulation of type 2 immune response</Keyword>
      <Ontology_ID>GO:0002829</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.</Detail>
      <Keyword>Negative regulation of angiogenesis</Keyword>
      <Ontology_ID>GO:0016525</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of alpha-beta T cell proliferation.</Detail>
      <Keyword>Positive regulation of alpha-beta T cell proliferation</Keyword>
      <Ontology_ID>GO:0046641</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of astrocyte chemotaxis.</Detail>
      <Keyword>Positive regulation of astrocyte chemotaxis</Keyword>
      <Ontology_ID>GO:2000464</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency, or extent of the process of immune complex clearance by monocytes or macrophages.</Detail>
      <Keyword>Positive regulation of immune complex clearance by monocytes and macrophages</Keyword>
      <Ontology_ID>GO:0090265</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Positive regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050729</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a T-helper 17 cell in response to an external stimulus.</Detail>
      <Keyword>T-helper 17 cell chemotaxis</Keyword>
      <Ontology_ID>GO:0035705</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of monocyte extravasation.</Detail>
      <Keyword>Positive regulation of monocyte extravasation</Keyword>
      <Ontology_ID>GO:2000439</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>139</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>26</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA</Protein_Seq>
    <DNA_Seq>TTTATTCTCTGGAACATGAAACATTCTGTTGTGCTCATATCATGCAAATTATCACTAGTAGGAGAGCAGAGAGTGGAAATGTTCCAGGTATAAAGACCCACAAGATAAAGAAGCTCAGAGTCGTTAGAAACAGGAGCAGATGTACAGGGTTTGCCTGACTCACACTCAAGGTTGCATAAGCAAGATTTCAAAATTAATCCTATTCTGGAGACCTCAACCCAATGTACAATGTTCCTGACTGGAAAAGAAGAACTATATTTTTCTGATTTTTTTTTTCAAATCTTTACCATTAGTTGCCCTGTATCTCCGCCTTCACTTTCTGCAGGAAACTTTATTTCCTACTTCTGCATGCCAAGTTTCTACCTCTAGATCTGTTTGGTTCAGTTGCTGAGAAGCCTGACATACCAGGACTGCCTGAGACAAGCCACAAGCTGAACAGAGAAAGTGGATTGAACAAGGACGCATTTCCCCAGTACATCCACAACATGCTGTCCACATCTCGTTCTCGGTTTATCAGAAATACCAACGAGAGCGGTGAAGAAGTCACCACCTTTTTTGATTATGATTACGGTGCTCCCTGTCATAAATTTGACGTGAAGCAAATTGGGGCCCAACTCCTGCCTCCGCTCTACTCGCTGGTGTTCATCTTTGGTTTTGTGGGCAACATGCTGGTCGTCCTCATCTTAATAAACTGCAAAAAGCTGAAGTGCTTGACTGACATTTACCTGCTCAACCTGGCCATCTCTGATCTGCTTTTTCTTATTACTCTCCCATTGTGGGCTCACTCTGCTGCAAATGAGTGGGTCTTTGGGAATGCAATGTGCAAATTATTCACAGGGCTGTATCACATCGGTTATTTTGGCGGAATCTTCTTCATCATCCTCCTGACAATCGATAGATACCTGGCTATTGTCCATGCTGTGTTTGCTTTAAAAGCCAGGACGGTCACCTTTGGGGTGGTGACAAGTGTGATCACCTGGTTGGTGGCTGTGTTTGCTTCTGTCCCAGGAATCATCTTTACTAAATGCCAGAAAGAAGATTCTGTTTATGTCTGTGGCCCTTATTTTCCACGAGGATGGAATAATTTCCACACAATAATGAGGAACATTTTGGGGCTGGTCCTGCCGCTGCTCATCATGGTCATCTGCTACTCGGGAATCCTGAAAACCCTGCTTCGGTGTCGAAACGAGAAGAAGAGGCATAGGGCAGTGAGAGTCATCTTCACCATCATGATTGTTTACTTTCTCTTCTGGACTCCCTATAATATTGTCATTCTCCTGAACACCTTCCAGGAATTCTTCGGCCTGAGTAACTGTGAAAGCACCAGTCAACTGGACCAAGCCACGCAGGTGACAGAGACTCTTGGGATGACTCACTGCTGCATCAATCCCATCATCTATGCCTTCGTTGGGGAGAAGTTCAGAAGCCTTTTTCACATAGCTCTTGGCTGTAGGATTGCCCCACTCCAAAAACCAGTGTGTGGAGGTCCAGGAGTGAGACCAGGAAAGAATGTGAAAGTGACTACACAAGGACTCCTCGATGGTCGTGGAAAAGGAAAGTCAATTGGCAGAGCCCCTGAAGCCAGTCTTCAGGACAAAGAAGGAGCCTAGAGACAGAAATGACAGATCTCTGCTTTGGAAATCACACGTCTGGCTTCACAGATGTGTGATTCACAGTGTGAATCTTGGTGTCTACGTTACCAGGCAGGAAGGCTGAGAGGAGAGAGACTCCAGCTGGGTTGGAAAACAGTATTTTCCAAACTACCTTCCAGTTCCTCATTTTTGAATACAGGCATAGAGTTCAGACTTTTTTTAAATAGTAAAAATAAAATTAAAGCTGAAAACTGCAACTTGTAAATGTGGTAAAGAGTTAGTTTGAGTTACTATCATGTCAAACGTGAAAATGCTGTATTAGTCACAGAGATAATTCTAGCTTTGAGCTTAAGAATTTTGAGCAGGTGGTATGTTTGGGAGACTGCTGAGTCAACCCAATAGTTGTTGATTGGCAGGAGTTGGAAGTGTGTGATCTGTGGGCACATTAGCCTATGTGCATGCAGCATCTAAGTAATGATGTCGTTTGAATCACAGTATACGCTCCATCGCTGTCATCTCAGCTGGATCTCCATTCTCTCAGGCTTGCTGCCAAAAGCCTTTTGTGTTTTGTTTTGTATCATTATGAAGTCATGCGTTTAATCACATTCGAGTGTTTCAGTGCTTCGCAGATGTCCTTGATGCTCATATTGTTCCCTATTTTGCCAGTGGGAACTCCTAAATCAAGTTGGCTTCTAATCAAAGCTTTTAAACCCTATTGGTAAAGAATGGAAGGTGGAGAAGCTCCCTGAAGTAAGCAAAGACTTTCCTCTTAGTCGAGCCAAGTTAAGAATGTTCTTATGTTGCCCAGTGTGTTTCTGATCTGATGCAAGCAAGAAACACTGGGCTTCTAGAACCAGGCAACTTGGGAACTAGACTCCCAAGCTGGACTATGGCTCTACTTTCAGGCCACATGGCTAAAGAAGGTTTCAGAAAGAAGTGGGGACAGAGCAGAACTTTCACCTTCATATATTTGTATGATCCTAATGAATGCATAAAATGTTAAGTTGATGGTGATGAAATGTAAATACTGTTTTTAACAACTATGATTTGGAAAATAAATCAATGCTATAACTATGTTGAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Perinuclear region of cytoplasm</CellLocal>
      <Ontology_ID>GO:0048471</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Dendrite</CellLocal>
      <Ontology_ID>GO:0030425</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Perikaryon</CellLocal>
      <Ontology_ID>GO:0043204</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CCR2</Gene_Name>
    <Gene_Alias>CMKBR2</Gene_Alias>
    <Gene_ID>729230</Gene_ID>
    <Genbank_ACCN>NM_001123041</Genbank_ACCN>
    <Protein_ACCN>NP_001116513</Protein_ACCN>
    <HGNC_ID>1603</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/729230</Gene_URL>
    <UCSC_ID>uc003cpm.4</UCSC_ID>
    <EMBL_ID>ENSG00000121807</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Aids, Delayed/rapid Progression to</Disease_Name>
      <Disease_Detail>Aids</Disease_Detail>
      <Disease_DB>ADS008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aids_delayed_rapid_progression_to?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Anterior Uveitis</Disease_Name>
      <Disease_Detail>Idiopathic Anterior Uveitis</Disease_Detail>
      <Disease_DB>IDP049</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_anterior_uveitis?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aids, Slow Progression to</Disease_Name>
      <Disease_Detail>Aids</Disease_Detail>
      <Disease_DB>ADS010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aids_slow_progression_to?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hiv-1</Disease_Name>
      <Disease_Detail>Hiv-1</Disease_Detail>
      <Disease_DB>HV1006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hiv_1?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uveitis</Disease_Name>
      <Disease_Detail>Uveitis</Disease_Detail>
      <Disease_DB>UVT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uveitis?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cytomegalovirus Retinitis</Disease_Name>
      <Disease_Detail>Cytomegalovirus Retinitis</Disease_Detail>
      <Disease_DB>CYT005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cytomegalovirus_retinitis?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hiv1 Infection</Disease_Name>
      <Disease_Detail>Hiv1 Infection</Disease_Detail>
      <Disease_DB>HV1007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hiv1_infection?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Anterior Uveitis</Disease_Name>
      <Disease_Detail>Anterior Uveitis</Disease_Detail>
      <Disease_DB>ANT034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/anterior_uveitis?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hiv Infection, Susceptibility/</Disease_Name>
      <Disease_Detail>Hiv1 Infection</Disease_Detail>
      <Disease_DB>HVN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hiv_infection_susceptibility_?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Secondary Progressive Multiple Sclerosis</Disease_Name>
      <Disease_Detail>Secondary Progressive Multiple Sclerosis</Disease_Detail>
      <Disease_DB>SCN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/secondary_progressive_multiple_sclerosis?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Age Related Macular Degeneration</Disease_Name>
      <Disease_Detail>Age Related Macular Degeneration</Disease_Detail>
      <Disease_DB>AGR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/age_related_macular_degeneration?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rapid Progression to Aids from Hiv1 Infection</Disease_Name>
      <Disease_Detail>Aids</Disease_Detail>
      <Disease_DB>RPD004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rapid_progression_to_aids_from_hiv1_infection?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acquired Immunodeficiency Syndrome</Disease_Name>
      <Disease_Detail>Acquired Immunodeficiency Syndrome</Disease_Detail>
      <Disease_DB>ACQ007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acquired_immunodeficiency_syndrome?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Aids, Rapid Progression to</Disease_Name>
      <Disease_Detail>Aids</Disease_Detail>
      <Disease_DB>ADS007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/aids_rapid_progression_to?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hiv/aids</Disease_Name>
      <Disease_Detail>Aids</Disease_Detail>
      <Disease_DB>HVD003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hiv_aids?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hiv-1 Viremia</Disease_Name>
      <Disease_Detail>Hiv-1 Viremia</Disease_Detail>
      <Disease_DB>HV1005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hiv_1_viremia?search=CCR2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rheumatoid Arthritis</Disease_Name>
      <Disease_Detail>Rheumatoid Arthritis</Disease_Detail>
      <Disease_DB>RHM011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rheumatoid_arthritis?search=CCR2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of C-C chemokine receptor type 2</PDB_Title>
      <PDB_ID>ASD10910000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04060</Pathway_ID>
      <Pathway_Title>Cytokine-cytokine receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Create_Date>2013-11-12</Create_Date>
</Organism_Record>